Evidence map›Paper›PMID 40005377›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Optical Coherence Tomography Angiography Flow Signal in Non-Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Treated with Faricimab.

Max Brinkmann, Tom Müller, Marco Köster, Jakob Schweighofer, Mathis Danckwardt, Giuseppe Giannaccare, Paola Marolo, Enrico Borrelli, Michele Reibaldi, Yosuf El-Shabrawi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Max BrinkmannDepartment of Ophthalmology, Klinikum Klagenfurt, 9020 Klagenfurt, Austria.
Tom MüllerDepartment of Ophthalmology, Klinikum Klagenfurt, 9020 Klagenfurt, Austria.ORCID 0009-0009-9204-4898
Marco KösterFaculty of Medicine, Medical University of Graz, 8010 Graz, Austria.
Jakob SchweighoferDepartment of Ophthalmology, Universitätsklinikum Wiener Neustadt, 1090 Vienna, Austria.
Mathis DanckwardtDepartment of Ophthalmology, Universitätsklinikum Schleswig-Holstein, 23564 Lübeck, Germany.
Giuseppe GiannaccareEye Clinic, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.ORCID 0000-0003-2617-0289
Paola MaroloDepartment of Ophthalmology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-8881-0926
Enrico BorrelliDepartment of Ophthalmology, University of Turin, 10126 Turin, Italy.ORCID 0000-0003-2815-5031
Michele ReibaldiDepartment of Ophthalmology, University of Turin, 10126 Turin, Italy.ORCID 0000-0003-1368-6729
Yosuf El-ShabrawiDepartment of Ophthalmology, Klinikum Klagenfurt, 9020 Klagenfurt, Austria.
Mario Damiano ToroEye Clinic, Public Health Department, University of Naples Federico II, 80133 Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AngiographyMacular DegenerationTomography, Optical CoherenceAgedAged, 80 and overAngiogenesis InhibitorsAngiopoietin-2Antibodies, BispecificChoroidChoroidal NeovascularizationFemaleFluorescein AngiographyHumansIntravitreal InjectionsMaleMiddle AgedAngiogenesis InhibitorsAngiopoietin-2Antibodies, BispecificfaricimabVascular Endothelial Growth Factor AAMDangiopoietin 2anti-VEGFchoroidFaricimabOCTA

Identifiers

PMID40005377
PMCPMC11857220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.